CDC/IDSA Lyme Criteria - IgG

Negative

A negative result for CDC/IDSA Lyme Criteria - IgG indicates that the test did not detect the presence of IgG antibodies specific to Borrelia burgdorferi, the bacterium responsible for Lyme disease, in sufficient levels to meet the diagnostic criteria set by the Centers for Disease Control and Prevention (CDC) or the Infectious Diseases Society of America (IDSA).

Here’s what it typically means when the IgG result is negative according to the CDC/IDSA Lyme criteria:

1. No Evidence of Recent or Past Lyme Disease Exposure

  • A negative IgG result generally suggests that the individual has not been exposed to Borrelia burgdorferi recently or in the past in a way that would have triggered an IgG antibody response. This could indicate that the person has not been infected with Lyme disease, or if they were, the immune response was not strong enough to produce detectable IgG levels.

2. Early-Stage or Acute Infection (IgM Antibodies)

  • In the early stages of a Lyme disease infection, especially during the first few weeks after the tick bite, the IgM antibodies (which are the first antibodies produced by the body) tend to be the most prominent. Therefore, a negative IgG result may simply reflect the fact that the infection is too recent for IgG antibodies to have developed. In such cases, an IgM test may still be positive, and a follow-up test is often recommended after a few weeks to check for IgG development.

3. Possible False Negative

  • There is also the possibility of a false negative result, where the immune system hasn't yet produced enough IgG antibodies to be detectable, even if the individual has Lyme disease. This can occur in the very early or late stages of infection or in cases where the immune system doesn't respond strongly to the bacteria.

4. Chronic or Persisting Infection

  • If someone is experiencing symptoms consistent with Lyme disease but their IgG result is negative, it may suggest that they do not have a chronic or persistent infection, as IgG antibodies typically remain elevated in chronic cases. However, Lyme disease can present in various ways, and further testing (such as a PCR test or additional antibody tests) and clinical evaluation may be needed to assess the possibility of chronic or persistent infection.

5. Cross-Reactivity or Alternative Diagnoses

  • A negative result does not completely rule out Lyme disease, especially if the symptoms are consistent with the disease but the test does not meet the criteria. Some individuals may have cross-reactivity with other infections or immune system disorders that could impact test accuracy. In such cases, a different diagnosis may need to be explored.

Conclusion

A negative CDC/IDSA Lyme Criteria - IgG result typically suggests that the individual has not been exposed to Lyme disease in a way that would produce detectable IgG antibodies. However, if Lyme disease is suspected based on symptoms, it’s important to consider additional tests, such as IgM testing, PCR testing, or repeat testing after some time. Consulting with a healthcare provider for further evaluation and diagnosis is crucial to ensure that Lyme disease or other conditions are not missed.

CDC/IDSA Lyme Criteria - IgG
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond CDC/IDSA Lyme Criteria - IgG — 10,000+ markers explained
One CDC/IDSA Lyme Criteria - IgG result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro